ALVO logo

Alvotech (ALVO)

Profile

Full Name

Alvotech

Ticker Symbol

ALVO

Exchange

NASDAQ

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Country

Luxembourg

IPO

June 16, 2022

Indexes

Not included

Website

http://www.alvotech.com

Employees

1012

Key Details

Price

$9.27

Market Cap

$2.80B(Mid cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$489.68M(+435.56% YoY)

Annual EPS

-$0.87(+64.20% YoY)

PE Ratio

-

Next earnings date

May 8, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$9.27
ALVO price is $9.27

Price All-time High

$17.05
ALVO price is currently -45.63% below its historical high of $17.05

Price Most Recent Change

+0.76%
ALVO price was up +0.76% on Apr 3, 2025

Price YTD Change

-31.59%
ALVO price is down -31.59% since January 1st

Price 1-year Change

-20.7%
ALVO price is down -20.7% year-on-year

Price 3-year Change

-
ALVO price 3-year change is unknown

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market Cap

$2.80B
ALVO market capitalization is $2.80 billion

Market Cap 3-year Change

-
ALVO market capitalization 3-year change is unknown

Market Cap All-time High

$4.72B
ALVO market capitalization is currently -40.75% below its historical high of $4.72 billion

Market Cap Sector Rank

85.89%
ALVO market capitalization is higher than 85.89% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+7.95%
ALVO shares outstanding is up +7.95% year-on-year

Shares Outstanding 3-Year Change

-
ALVO shares outstanding 3-year change is unknown

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.38
ALVO beta is 0.38

200-day SMA

$12.01
ALVO price is currently -22.84% below its 200-day simple moving average

50-day SMA

$11.67
ALVO price is currently -20.57% below its 50-day simple moving average

RSI

25.33
ALVO 14-day relative strength index is 25.33

Volume

0.94
ALVO 30-day relative volume is 0.94

ATR

$0.43
ALVO average true range is $0.43

10-day Historical Volatility

64.64%
ALVO 10-day historical volatility is 64.64%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$489.68M
ALVO annual revenue is $489.68 million

Revenue Analysts Estimate

$637.12M
ALVO annual revenue is currently -23.14% lower than the consensus analysts' forecast

Revenue 1-year Change

+435.56%
ALVO annual revenue is up +435.56% year-on-year

Revenue Sector Rank

75.11%
ALVO annual revenue is higher than 75.11% of companies in Healthcare sector

EPS

EPS

-$0.87
ALVO annual earnings per share is -$0.87

EPS Analysts Estimate

$0.20
ALVO annual earnings per share is currently -533.92% lower than the consensus analysts' forecast

EPS 1-year Change

+64.2%
ALVO annual earnings per share is up +64.2% year-on-year

EPS Sector Rank

59.95%
ALVO annual earnings per share is higher than 59.95% of companies in Healthcare sector

Profit

Gross Profit

$304.37M
ALVO annual gross profit is $304.37 million

Gross Margin

62.16%
ALVO annual gross profit margin is 62.16%

Operating Profit

$69.64M
ALVO annual operating income is $69.64 million

Operating Margin

14.22%
ALVO annual operating profit margin is 14.22%

Net Income

-$231.86M
ALVO annual net profit is -$231.86 million

Net Margin

-47.35%
ALVO annual net profit margin is -47.35%

Expenses

Total Expenses

$420.04M
ALVO annual total expenses is $420.04 million

Operating Expenses

$234.73M
ALVO annual total operating expenses is $234.73 million

Cost Of Goods Sold

$185.31M
ALVO annual cost of goods sold is $185.31 million

Selling, General & Administrative Expenses

$61.45M
ALVO annual SGA is $61.45 million

Depreciation And Amortization

$31.30M
ALVO annual depreciation & amortization is $31.30 million

Interest Expense

$153.99M
ALVO annual interest expense is $153.99 million

Income Tax

$14.30M
ALVO annual income tax is $14.30 million

EBIT & EBITDA

EBIT

-$63.58M
ALVO annual earnings before interest & taxes is -$63.58 million

EBITDA

-$32.27M
ALVO annual EBITDA is -$32.27 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total Assets

$1.22B
ALVO annual total assets is $1.22 billion

Non Current Assets

$766.38M
ALVO annual long term assets is $766.38 million

Current Assets

$455.02M
ALVO annual total current assets is $455.02 million

Cash And Cash Equivalents

$51.43M
ALVO annual cash & cash equivalents is $51.43 million

Accounts Receivable

$160.22M
ALVO annual accounts receivable is $160.22 million

Inventory

$127.89M
ALVO annual inventory is $127.89 million

Liabilities

Total Liabilities

$1.63B
ALVO annual total liabilities is $1.63 billion

Long Term Liabilities

$1.44B
ALVO annual total long term liabilities is $1.44 billion

Current Liabilities

$193.40M
ALVO annual total current liabilities is $193.40 million

Accounts Payable

$67.13M
ALVO annual accounts payable is $67.13 million

Debt

Total Debt

$1.19B
ALVO annual total debt is $1.19 billion

Total Debt 1-year Change

+10.67%
ALVO annual total debt is up +10.67% year-on-year

Long Term Debt

$1.15B
ALVO annual long term debt is $1.15 billion

Short Term Debt

$42.22M
ALVO annual short term debt is $42.22 million

Equity & Capital

Shareholders Equity

-$412.77M
ALVO annual stockholders equity is -$412.77 million

Book Value

-$412.77M
ALVO annual book value is -$412.77 million

Retained Earnings

-$2.44B
ALVO annual retained earnings is -$2.44 billion

Working Capital

$261.62M
ALVO annual working capital is $261.62 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash From Operations

-$236.84M
ALVO annual cash flow from operations is -$236.84 million

Cash From Operations 1-year Change

+24.13%
ALVO annual cash flow from operations is up +24.13% year-on-year

Cash From Investing

-$18.87M
ALVO annual cash flow from investing activities is -$18.87 million

Cash From Investing 1-year Change

+59.28%
ALVO annual cash flow from investing activities is up +59.28% year-on-year

Cash From Financing

$297.31M
ALVO annual cash flow from financing activities is $297.31 million

Cash From Financing 1-year Change

-1.33%
ALVO annual cash flow from financing activities is down -1.33% year-on-year

CAPEX

CAPEX

$57.00M
ALVO annual capital expenditures is $57.00 million

CAPEX 1-year Change

+22.65%
ALVO annual capital expenditures is up +22.65% year-on-year

Free Cash Flow

Free Cash Flow

-$293.84M
ALVO annual free cash flow is -$293.84 million

Free Cash Flow 1-year Change

+18.07%
ALVO annual free cash flow is up +18.07% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross Margin

62.16%
ALVO annual gross profit margin is 62.16%

Operating Margin

14.22%
ALVO annual operating profit margin is 14.22%

Net Margin

-47.35%
ALVO annual net profit margin is -47.35%

ROA & ROE

ROA

-21.36%
ALVO annual return on assets is -21.36%

ROE

56.17%
ALVO annual return on equity is 56.17%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

-
ALVO price to earnings ratio value is unknown

PE Ratio Sector Rank

-
ALVO price to earnings ratio is unknown

PB Ratio

PB Ratio

-6.78
ALVO price to book ratio is -6.78

PB Ratio Sector Rank

2.96%
ALVO price to book ratio is higher than 2.96% of companies in Healthcare sector

PS Ratio

PS Ratio

5.71
ALVO price to sales ratio is 5.71

PS Ratio Sector Rank

68.63%
ALVO price to sales ratio is higher than 68.63% of companies in Healthcare sector

Enterprise value

Enterprise Value

$3.94B
ALVO enterprise value is $3.94 billion

Enterprise Value Sector Rank

86.52%
ALVO enterprise value is higher than 86.52% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

33.67
ALVO EV/EBITDA is 33.67

EV/EBITDA Sector Rank

95.12%
ALVO EV/EBITDA is higher than 95.12% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current Ratio

2.35
ALVO annual current ratio is 2.35

Quick Ratio

1.69
ALVO annual quick ratio is 1.69

Leverage

Debt To Equity

-2.59
ALVO annual debt to equity ratio is -2.59

Interest Coverage Ratio

-0.41
ALVO annual interest coverage ratio is -0.41

Risk & Stability

Piotroski F-Score

3
ALVO piotroski f-score is 3

Altman Z-Score

-1.28
ALVO altman z-score is -1.28

Analyst ratings

Recent major analysts updates

Feb 14, 25 UBS
Buy
Jul 25, 24 Barclays
Overweight
May 24, 24 Barclays
Overweight
Mar 22, 24 Barclays
Overweight
Jan 29, 24 Barclays
Overweight
Oct 20, 23 Citigroup
Neutral
Sep 21, 23 Barclays
Equal-Weight
Mar 7, 23 Deutsche Bank
Hold
Sep 7, 22 Morgan Stanley
Equal-Weight
Sep 6, 22 Citigroup
Sell

Institutional Ownership

Similar stocks

CRSP logo
CRISPR Therapeutics AG (CRSP)
PTGX logo
Protagonist Therapeutics (PTGX)
SRRK logo
Scholar Rock Holding (SRRK)
XRAY logo
DENTSPLY SIRONA (XRAY)
NVST logo
Envista Holdings (NVST)
Concentra Group Holdings Parent (CON)
PDCO logo
Patterson Companies (PDCO)
VKTX logo
Viking Therapeutics (VKTX)
APLS logo
Apellis Pharmaceuticals (APLS)
  • What is the ticker symbol for Alvotech?
  • Does Alvotech pay dividends?
  • What sector is Alvotech in?
  • What industry is Alvotech in?
  • What country is Alvotech based in?
  • When did Alvotech go public?
  • Is Alvotech in the S&P 500?
  • Is Alvotech in the NASDAQ 100?
  • Is Alvotech in the Dow Jones?
  • When was Alvotech's last earnings report?
  • When does Alvotech report earnings?
  • Should I buy Alvotech stock now?

What is the ticker symbol for Alvotech?

The ticker symbol for Alvotech is NASDAQ:ALVO

Does Alvotech pay dividends?

No, Alvotech does not pay dividends

What sector is Alvotech in?

Alvotech is in the Healthcare sector

What industry is Alvotech in?

Alvotech is in the Drug Manufacturers - Specialty & Generic industry

What country is Alvotech based in?

Alvotech is headquartered in Luxembourg

When did Alvotech go public?

Alvotech's initial public offering (IPO) was on June 16, 2022

Is Alvotech in the S&P 500?

No, Alvotech is not included in the S&P 500 index

Is Alvotech in the NASDAQ 100?

No, Alvotech is not included in the NASDAQ 100 index

Is Alvotech in the Dow Jones?

No, Alvotech is not included in the Dow Jones index

When was Alvotech's last earnings report?

Alvotech's most recent earnings report was on Mar 27, 2025

When does Alvotech report earnings?

The next expected earnings date for Alvotech is May 8, 2025

Should I buy Alvotech stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page